Breast Cancer Research and Treatment

, Volume 36, Issue 2, pp 127–137 | Cite as

The role of vascular endothelial growth factor in pathological angiogenesis

  • Napoleone Ferrara


Vascular endothelial growth factor (VEGF) is a diffusible endothelial cell-specific mitogen and angiogenic factor that can also increase vascular permeability. By alternative splicing of mRNA, VEGF may exist as one of four different isoforms that have similar biological activities but differ markedly in targeting and bioavailability. The VEGF receptors are specifically expressed in the cell surface of vascular endothelial cells. Recent studies point to VEGF as a major regulator of physiological angiogenesis, such as developmental and reproductive angiogenesis. Furthermore, VEGF appears to be a crucial mediator of blood vessel growth associated with tumors and proliferative retinopathies. The VEGF mRNA is up-regulated in the majority of human tumors and the VEGF protein is increased in the aqueous and vitreous humors of patients with proliferative retinopathies. Anti-VEGF antibodies have the ability to suppress the growth of a variety of tumor cell lines in nude mice and also can inhibit angiogenesis in animal models of intraocular neovascularization. Therefore, strategies aimed at antagonizing VEGF may form the basis for an effective treatment of tumors and retinopathies. Furthermore, VEGF-induced angiogenesis is sufficient to achieve a therapeutic endpoint in models of coronary or limb ischemia.

Key words

vascular endothelial growth factor endothelium angiogenesis tumor growth ischemic disorders retinopathy rheumatoid arthritis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931–10934, 1992.Google Scholar
  2. 2.
    Klagsbrun M, D'Amore PA: Regulators of angiogenesis. Annu Rev Physiol 53:217–239, 1991.Google Scholar
  3. 3.
    Folkman J: What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 82:4–6, 1991.Google Scholar
  4. 4.
    Weidner N, Semple P, Welch W, Folkman J: Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. New Engl J Med 324:1–6, 1991.Google Scholar
  5. 5.
    Vartanian RK, Weidner N: Correlation of intramural endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation. Am J Pathol 144:1188–1194, 1994.Google Scholar
  6. 6.
    Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart M, Greenall M, Harris AL: Quantitative angiogenesis assessed by anti-PECAM antibodies: correlation with node metastasis and survival in breast cancer. Lancet 340:1120–1124, 1992.Google Scholar
  7. 7.
    Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875–1888, 1992.Google Scholar
  8. 8.
    Chodak GW, Haudenschild C, Gittes RF, Folkman J: Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann Surg 192:762–771, 1980.Google Scholar
  9. 9.
    Wakui S, Furusato M, Sasaki H, Akiyama A, Kinoshito I, Asano K, Tokuda T, Aizawa S, Ushigome S: Tumor angiogenesis in prostatic carcinoma with and without bone metastasis: a morphometric study. J Pathol 168:257–262, 1992.Google Scholar
  10. 10.
    Bigler SA, Deering RE, Brawer MK: Comparison of microscopic vascularity in benign and malignant prostatic tissue. Human Pathol 24:220–226, 1993.Google Scholar
  11. 11.
    Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA: Relation of neovascularization to metastasis of non-small cell lung carcinoma. Lancet 340:145–146, 1992.Google Scholar
  12. 12.
    Sillman F, Boyce J, Fruchter R: The significance of atypical vessels and neovascularization in cervical neoplasias. Am J Obstet Gynecol 139:154–157, 1981.Google Scholar
  13. 13.
    Srivastava A, Laidler P, Davies R, Horgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma. Am J Pathol 133:419–423, 1988.Google Scholar
  14. 14.
    Smith-McCune KS, Weidner N: Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54:804–808, 1994.Google Scholar
  15. 15.
    Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851–859, 1989.Google Scholar
  16. 16.
    Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18–32, 1992.Google Scholar
  17. 17.
    Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470–1478, 1989.Google Scholar
  18. 18.
    Ploüet J, Schilling J, Gospodarowicz D: Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J 8:3801–3807, 1989.Google Scholar
  19. 19.
    Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306–1309, 1989.Google Scholar
  20. 20.
    Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to platelet derived growth factor. Science 246:1309–1312, 1989.Google Scholar
  21. 21.
    Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806–1814, 1991.Google Scholar
  22. 22.
    Tisher E, Mitchell R, Hartmann T, Silva M, Gospodarowicz D, Fiddes J, Abraham J: The human gene for vascular endothelial growth factor. J Biol Chem 266:11947–11954, 1991.Google Scholar
  23. 23.
    Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521–532, 1992.Google Scholar
  24. 24.
    Jakeman LB, Armanini M, Phillips HS, Ferrara N: Developmental expression of binding sites and mRNA for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133:848–859, 1993.Google Scholar
  25. 25.
    Phillips HS, Hains J, Leung DW, Ferrara N: Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127:965–968, 1990.Google Scholar
  26. 26.
    Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N, Zeleznick AJ: Vascular endothelial growth factor mRNA expression in the primate ovary. Endocrinology 131:254–260, 1992.Google Scholar
  27. 27.
    Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E: Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91:2235–2243, 1993.Google Scholar
  28. 28.
    Banai S, Jaktlish MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein S, Unger E: Angiogenicinduced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183–2189, 1994.Google Scholar
  29. 29.
    Takeshita S, Zhung L, Brogi E, Kearney M, Pu L-Q, Bunting S, Ferrara N, Symes JF, Isner JM: Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments collateral vessel formation in a rabbit ischemic hindlimb model. J Clin Invest 93:662–670, 1994.Google Scholar
  30. 30.
    Takeshita S, Zheng LP, Cheng D, Riessen R, Weir L, Symes JF, Ferrara N, Isner JM: Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Proc Natl Acad Sci USA, in press.Google Scholar
  31. 31.
    Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841–844, 1993.Google Scholar
  32. 32.
    Ferrara N: Vascular endothelial growth factor. Trends Cardiovasc Med 3:244–250, 1993.Google Scholar
  33. 33.
    Aiello LP, Avery R, Arrigg R, Keyt B, Jampel H, Shah S, Pasquale L, Thieme H, Iwamoto M, Park JE, Nguyen H, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487, 1994.Google Scholar
  34. 34.
    Adamis AP, Shima DT, Tolentino M, Gragoudas E, Ferrara N, Folkman J, D'Amore PA, Miller JW: Inhibition of VEGF prevents ocular neovascularization in a primate model. Submitted.Google Scholar
  35. 35.
    Pepper MS, Ferrara N, Orci L, Montesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824–831, 1992.Google Scholar
  36. 36.
    Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K: Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 269:6271–6274, 1994.Google Scholar
  37. 37.
    Dvorak HF: Tumors: wounds that do not heal. Similarity between tumor stroma generation and wound healing. N Engl J Med 315:1650–1658, 1986.Google Scholar
  38. 38.
    Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902–908, 1991.Google Scholar
  39. 39.
    Unemori E, Ferrara N, Bauer EA, Amento EP: Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153:557–562, 1992.Google Scholar
  40. 40.
    Gross J, Nagai Y: Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci USA 54:1197–1204, 1965.Google Scholar
  41. 41.
    Pepper MS, Montesano R: Proteolytic balance and capillary morphogenesis. Cell Diff Dev 32:319–331, 1990.Google Scholar
  42. 42.
    Ku DD, Zaleski JK, Liu S, Brock T: Vascular endothelial growth factor induces EDRF-dependent relaxation of coronary arteries. Am J Physiol 265: H586–592, 1993.Google Scholar
  43. 43.
    Park JE, Chen H, Winer J, Houck K, Ferrara N: Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646–25654, 1994.Google Scholar
  44. 44.
    Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG: Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267–9271, 1991.Google Scholar
  45. 45.
    Hauser S, Weich HA: A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9:259–268, 1993.Google Scholar
  46. 46.
    Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845, 1992.Google Scholar
  47. 47.
    Goldberg MA, Schneider TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269:4355–4361, 1994.Google Scholar
  48. 48.
    Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031–26037, 1992.Google Scholar
  49. 49.
    Park JE, Keller G-A, Ferrara N: The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of ECM-bound VEGF. Mol Biol Cell 4:1317–1326, 1993.Google Scholar
  50. 50.
    Mignatti P, Tsuboi R, Robbins E, Rifkin DB: In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 108:671–682, 1989.Google Scholar
  51. 51.
    Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P, Flaumenhaft R, Mignatti P: Growth factor control of extracellular proteolysis. Cell Differ Dev 32:313–318, 1990.Google Scholar
  52. 52.
    Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S, Pozzatti RO: Expression of matrix metalloproteinases in transformed rat cell lines of high and low metastatic potential. Cancer Res 52:4942–4947, 1992.Google Scholar
  53. 53.
    Vaisman N, Gospodarowicz D, Neufeld G: Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 265:19461–19469, 1990.Google Scholar
  54. 54.
    Ploüet J, Moukadiri HJ: Characterization of the receptors to vasculotropin on bovine adrenal cortexderived capillary endothelial cells. J Biol Chem 265:22071–22075, 1990.Google Scholar
  55. 55.
    Shen H, Clauss M, Ryan J, Schmidt AM, Tijburg P, Borden L, Connolly DT, Stern D, Kao J: Characterization of vascular permeability factor/vascular endothelial growth factor receptors in mononuclear phagocytes. Blood 81:2767–2773, 1993.Google Scholar
  56. 56.
    Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244–253, 1992.Google Scholar
  57. 57.
    deVries C, Escobedo JA, Ueno H, Houck KA, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989–991, 1992.Google Scholar
  58. 58.
    Terman BI, Vermazen MD, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 34:1578–1586, 1992.Google Scholar
  59. 59.
    Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A: High affinity binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835–846, 1993.Google Scholar
  60. 60.
    Quinn T, Peters KG, deVries C, Ferrara N, Williams LT: Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90: 7533–7537, 1993.Google Scholar
  61. 61.
    Shibuya M, Yamaguchi S, Yamane A, Ikada T, Tojo T, Matsushime H, Sato M: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to thefms family. Oncogene 8:519–527, 1990.Google Scholar
  62. 62.
    Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB: Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:519–524, 1991.Google Scholar
  63. 63.
    Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR: A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 88:9026–9030, 1991.Google Scholar
  64. 64.
    Kendell RL, Thomas KA: Inhibition of vascular endothelial growth factor by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90:10705–10709, 1993.Google Scholar
  65. 65.
    Peters KG, deVries C, Williams LT: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90:8915–8919, 1993.Google Scholar
  66. 66.
    Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin C-H: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988–26995, 1994.Google Scholar
  67. 67.
    Senger D, Perruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5269–5275, 1986.Google Scholar
  68. 68.
    Rosenthal R, Megyesi JF, Henzel WJ, Ferrara N, Folkman J: Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor. Growth Factors 4:53–59, 1990.Google Scholar
  69. 69.
    Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, Tarada M: Markedly increased amounts of messenger RNA for VEGF and PlGF in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233–4237, 1994.Google Scholar
  70. 70.
    Olson TA, Mohanraj D, Carson LF, Ramakrishnan S: Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 54:276–280, 1994.Google Scholar
  71. 71.
    Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727–4735, 1993.Google Scholar
  72. 72.
    Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth is a potential tumour angiogenesis factor in vivo. Nature 359:845–847, 1992.Google Scholar
  73. 73.
    Phillips HS, Armanini M, Stavrou D, Ferrara N, Westphal M: Intense focal expression of vascular endothelial growth factor mRNA in human intracranial neoplasms: Association with regions of necrosis. Int J Oncol 2:913–919, 1993.Google Scholar
  74. 74.
    Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH: Expression of the vascular permeability/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91: 153–159, 1993.Google Scholar
  75. 75.
    Toi M, Hoshima S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85:1045–1049, 1994.Google Scholar
  76. 76.
    Ferrara N, Winer J, Burton T, Rowland A, Siegel M, Phillips HS, Terrell T, Keller G-A, Levinson AD: Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 91:160–170, 1993.Google Scholar
  77. 77.
    Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth is inhibited in vivo by a negative dominant Flk-1 mutant. Nature 367:576–579, 1994.Google Scholar
  78. 78.
    Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95:1789–1797, 1995Google Scholar
  79. 79.
    Altman RJ, Mesiano S, Ferrara N, Jaffe RB: Vascular endothelial growth factor is essential for human ovarian carcinoma growth in vivo. Submitted.Google Scholar
  80. 80.
    Patz A: Studies on retinal neovascularization. Invest Ophthalmol Vis Sci 19:1133–1138, 1980.Google Scholar
  81. 81.
    Michaelson IC: The mode of development of the vascular system of the retina with some observations on its significance for certain retinal disorders. Trans Ophthalmol Soc UK 68:137–180, 1948.Google Scholar
  82. 82.
    Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Losche C, Rollman R, Schatz H: Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3 increase in neovascular disease. J Clin Invest 92:2620–2625, 1993.Google Scholar
  83. 83.
    Hannehan A, deJuan E, Lutti GA, Fox GM, Schiffer S, Hjelmeland LM: Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalm 109:1005–1011, 1991.Google Scholar
  84. 84.
    Adamis AP, Miller JW, Bernal M-T, D'Amico D, Folkman J, Yeo T-K, Yeo K-T: Increased vascular endothelial growth factor in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450, 1994.Google Scholar
  85. 85.
    Miller JW, Adamis AP, Shima DT, d'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, Yeo T-K, Yeo K-T. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular neovascularization in a primate model. Am J Pathol 145:574–584, 1994.Google Scholar
  86. 86.
    Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong W-L, Pope RM, Ferrara N: Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149–4156, 1994.Google Scholar
  87. 87.
    Fava RA, Olsen NJ, Spencer-Green G, Yeo T-K, Yeo K-T, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF: Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid arthritis. J Exp Med 180:340–346, 1994.Google Scholar
  88. 88.
    Fassbender HJ, Simling-Annefeld M: The potential aggressiveness of synovial tissue in rheumatoid arthritis. J Pathol 139:399–406, 1983.Google Scholar
  89. 89.
    Hamilton J: Hypothesis: In vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus. J Rheumatol 10:845–851, 1976.Google Scholar
  90. 90.
    Thompson RW, D'Amore PA: Recruitment of growth and collateral circulation.In: Zelenock GB, D'Alecy LG, Fantone JC III, Shlafer M, Stanley JC (eds) Clinical Ischemic Syndromes: Mechanisms and Consequences of Tissue Injury. Mosby, St. Louis, 1990, pp 117–134.Google Scholar
  91. 91.
    Graor RA, Gray BH: Interventional treatment of peripheral vascular disease.In: Young JR, Graor RA, Olin JW, Bartholomew JR (eds) Peripheral Vascular Diseases. Mosby, St. Louis, 1991, pp 111–133.Google Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Napoleone Ferrara
    • 1
  1. 1.Department of Cardiovascular ResearchGenentech, Inc.South San FranciscoUSA

Personalised recommendations